Growth differentiation factor-15 and all-cause mortality in patients with suspected myocardial infarction.

Walter, Joan; Nestelberger, Thomas; Boeddinghaus, Jasper; Twerenbold, Raphael; Croton, Lukas; Badertscher, Patrick; Wildi, Karin; Wussler, Desiree; du Fay de Lavallaz, Jeanne; Mueller, Christian (2019). Growth differentiation factor-15 and all-cause mortality in patients with suspected myocardial infarction. International journal of cardiology, 292, pp. 241-245. Elsevier 10.1016/j.ijcard.2019.04.088

Text 1-s2.0-S0167527319305522-main.pdf - Published Version Restricted to registered users only Available under License Publisher holds Copyright. Download (651kB)

BACKGROUND

To assess the prognostic performance of Growth differentiation factor-15 (GDF-15) concentrations in unselected patients presenting with suspected acute myocardial infarction (AMI) and adjudication based on high-sensitivity cardiac troponin (hs-cTn).

METHODS AND RESULTS

In an ongoing prospective multicenter diagnostic study, consecutive patients presenting with suspected AMI to the emergency department and available GDF-15 and hs-cTnT concentrations were included. Adjudication of AMI was performed central by two independent cardiologists using all available clinical information including cardiac imaging and serial hs-cTn concentrations. Overall, 718 patients were included, with 23% (162/718) having an adjudicated diagnosis of AMI. The cumulative incidence of death within 2 years was 19% in patients with AMI (30 deaths in 162 patients) versus 5% in patients without AMI (25 deaths in 556 patients; P < 0.001). In AMI patients, GDF-15 provided an AUC of 0.89 (95% confidence interval [CI] 0.83-0.94) for 2-year death versus 0.55 (95% CI 0.44-0.66) for hs-cTnT (P < 0.001). A GDF-15 cutoff of ≤1560 ng/L predicted 2-year survival in 47% (76/162) of AMI patients and had 100% sensitivity (95% CI 88-100%) for 2-year death. In patients without AMI, GDF-15 provided an AUC of 0.83 (95% CI 0.76-0.89) versus 0.76 (95% CI 0.67-0.85) for hs-cTnT (P = 0.096). A GDF-15 cutoff of ≤886 ng/L predicted 2-year survival in 37% (203/556) of non-AMI patients and had 100% sensitivity (95% CI 86-100%) for 2-year death.

CONCLUSIONS

GDF-15 concentrations at emergency department presentation have a high predictive accuracy for all-cause death in patients with suspected AMI and allow the identification of a large proportion of AMI patients with very low mortality risk.

Interest & Impact

Downloads

1 since deposited on 27 Dec 2019
0 in the past 12 months

Citations

5 Citations in Web of Science ®
6 Citations in Scopus

Search

in Google Scholar™

Services

Actions (login required)

Edit item

Actions (login required)

Edit item